EL PRIMER PASO DE LA PALEONTOLOGIA. UNA CONFIRMACION QUE ILEGA DESPUES DE 25 SIGLOS. = LE PREMIER PAS DE LA PALEONTOLOGIE. UNE CONFIRMATION ATTENDUE DEPUIS 25 SIECLESIMPERATORI L.1977; BOL. R. SOC. ESP. HIST. NAT., SECC. GEOL.; ESP.; DA. 1977; VOL. 75; NO 1-4; PP. 77-83; 5 ILL.Article

DOCUMENTOS PARA EL ESTUDIO DEL CUATERNARIO ALICANTINO.IMPERATORI L.1966; ESTUD. GEOL.; ESP; 1966(12), VOL. 22, P. 229 A 233Miscellaneous

COPROLITOS EN EL CUATERNARIO DE AMBRONA. = COPROLITES DANS LE QUATERNAIRE DE AMBRONA.IMPERATORI L.1971; BOL. R. SOC. ESP. HIST. NAT., SECC. GEOL.; ESP; 1971, VOL. 69, NUM. 0002, P. 187 A 190Miscellaneous

Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agentsDAMIA, G; IMPERATORI, L; STEFANINI, M et al.International journal of cancer. 1996, Vol 66, Num 6, pp 779-783, issn 0020-7136Article

Dons d'organes et transplantation: qu'en pensent les soignants ? : Soins intensifs = What do hospital staff think of organ donation and transplantation ?IMPERATORI, L; GACHET, C; ECKERT, P et al.Médecine et hygiène. 2001, Vol 59, Num 2372, pp 2463-2467, issn 0025-6749, 4 p.Article

3-Methyladenine-DNA-glycosylase and O⁶-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell linesDAMIA, G; IMPERATORI, L; CITTI, L et al.British journal of cancer. 1996, Vol 73, Num 7, pp 861-865, issn 0007-0920Article

3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agentsIMPERATORI, L; DAMIA, G; TAVERNA, P et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 3, pp 533-537, issn 0143-3334Article

Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833GONZALEZ, O; COLOMBO, T; DE FUSCO, M et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 4, pp 335-340, issn 0344-5704Article

In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatinBELVEDERE, G; IMPERATORI, L; DAMIA, G et al.European journal of cancer (1990). 1996, Vol 32, Num 11, pp 2011-2018, issn 0959-8049Article

High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancerMATTIOLI, R; MASSACESI, C; BONSIGNORI, M et al.Annals of oncology. 2005, Vol 16, Num 7, pp 1147-1151, issn 0923-7534, 5 p.Article

Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trialMATTIOLI, R; LIPPE, P; LAICI, G et al.Anticancer research. 2004, Vol 24, Num 5B, pp 3257-3261, issn 0250-7005, 5 p.Article